2. Signaling Pathways
  3. Antibody-drug Conjugate/ADC Related
  4. Drug-Linker Conjugates for ADC
  5. Maytansinoids Isoform

Maytansinoids

 

Maytansinoids Related Products (18):

Cat. No. Product Name Effect Purity
  • HY-101070
    SMCC-DM1
    		98.53%
    SMCC-DM1 (DM1-SMCC) is a drug-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker SMCC to make antibody drug conjugate (ADC).
  • HY-12460
    SPDB-DM4
    		98.92%
    SPDB-DM4 is a drug-linker conjugate for ADC by using the maytansinebased payload (DM4, a tubulin inhibitor) via a SPDB linker, exhibiting potent anti-tumor activity.
  • HY-126682
    Mal-VC-PAB-DM1
    		99.12%
    Mal-VC-PAB-DM1 is a drug-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker Mal-VC-PAB .
  • HY-101141
    sulfo-SPDB-DM4
    sulfo-SPDB-DM4 is a drug-linker conjugate for ADC by using the maytansinebased payload (DM4, an antitubulin agent) via the sulfo-SPDB linker.
  • HY-101982A
    (Rac)-Lys-SMCC-DM1
    		98.18%
    (Rac)-Lys-SMCC-DM1 ((Rac)-Lys-Nε-MCC-DM1) is the racemate of Lys-SMCC-DM1 (HY-101982).
  • HY-136286
    MC-DM1
    MC-DM1 is a drug-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker MC to make antibody drug conjugate (ADC).
  • HY-101982
    Lys-SMCC-DM1
    Lys-SMCC-DM1 (Lys-Nε-MCC-DM1) is a drug-linker conjugates for ADC that can inhibit tubulin polymerization.
  • HY-126491
    SPP-DM1
    SPP-DM1 is a drug-linker conjugate for ADC with potent antitumor activity by using DM1 (a potent microtubule-disrupting agent), linked via the ADC linker SPP.
  • HY-136290
    Mc-Dexamethasone
    Mc-Dexamethasone is a drug-linker conjugate for ADC.
  • HY-136261
    DM1-PEG4-DBCO
    DM1-(PEG)4-DBCO is a drug-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody drug conjugate (ADC).
  • HY-128954
    Sulfo-PDBA-DM4
    Sulfo-PDBA-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Sulfo-PDBA to make antibody drug conjugate (ADC).
  • HY-126493
    DM4-SPDP
    DM4-SPDP is a drug-linker conjugate composed of a potent antitubulin agent DM4 and a linker SMCC to make antibody drug conjugate.
  • HY-136260
    DBCO-PEG4-Ahx-DM1
    DBCO-PEG4-Ahx-DM1 is a drug-linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO-PEG4-Ahx to make antibody drug conjugate (ADC).
  • HY-145663
    HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM
    HS-(CH2)3CO-L-Ala-D-Ala-L-Ala-NH-CH2-S-(CH2)5-CO-DM is a drug-linker (peptide-cleavable) conjugate for ADC.
  • HY-126494
    DM4-SMCC
    DM4-SMCC is a drug-linker conjugate for ADC with antitumor activity by using DM4 (an antitubulin agent), linked via the non-cleavable SMCC linker.
  • HY-136291
    Sulfo-SPDB-DGN462
    Sulfo-SPDB-DGN462 is a drug-linker conjugate for ADC.
  • HY-128960
    DBA-DM4
    DBA-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM1 and a linker SPDP to make antibody drug conjugate (ADC).
  • HY-141596
    Lys-Nε-SPDB-DM4
    Lys-Nε-SPDB-DM4 is a drug-linker conjugate composed of a potent a tubulin inhibitor DM4 and a linker Lys-Nε-SPDB to make antibody drug conjugate (ADC).